Molecularly-biochemical and neuropsychophysiological aspects of neuroprotective activity of mexidol during chronic immobilizational stress
| dc.contributor.author | Chekman, I. S. | |
| dc.contributor.author | Yakovleva, I. Yu. | |
| dc.contributor.author | Belenichev, I. F. | |
| dc.contributor.author | Gorchakova, N. A. | |
| dc.contributor.author | Buhtiyarova, N. V. | |
| dc.contributor.author | Бєленічев, Ігор Федорович | |
| dc.contributor.author | Бухтіярова, Ніна Вікторівна | |
| dc.date.accessioned | 2018-04-03T12:35:19Z | |
| dc.date.available | 2018-04-03T12:35:19Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | Abstract: It is found out that in models of rats’ chronic stress an oral administration of Mexidol (100 mg/kg) during 10 days decreases a degree of DNA oxidative modification markers (8-OHG), proteins APH and KPH, hyperproduction of NO, and activity of NO-synthase. Also it changes an expression of early gene c-Fos and increases a concentration of Bcl-2 in neurons of paraventricular nuclei of the hypothalamus. | uk_UK |
| dc.identifier.citation | Molecularly-biochemical and Neuropsychophysiological Aspects of Neuroprotective Activity of Mexidol during Chronic Immobilizational Stress / I. S. Chekman, I. Yu. Yakovleva, I. F. Belenichev, N. A. Gorchakova, N. V. Buhtiyarova // Molecular Pharmacology. – 2013. – Issue 2. – P. 1-6. | uk_UK |
| dc.identifier.issn | 0976-3856 | |
| dc.identifier.uri | https://zsmu.rosbai.com/handle/123456789/7554 | |
| dc.language.iso | en | uk_UK |
| dc.publisher | United States : American Society for Pharmacology and Experimental Therapeutics | uk_UK |
| dc.title | Molecularly-biochemical and neuropsychophysiological aspects of neuroprotective activity of mexidol during chronic immobilizational stress | uk_UK |
| dc.type | Article | uk_UK |